Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients

Neurological Sciences

Volumn 36, Issue 11, 2015, Pages 2053-2060

  Anagnostouli, Maria ^a   Christidi, Foteini ^a   Zalonis, Ioannis ^a   Nikolaou, Chryssoula ^a   Lyrakos, Dimitrios ^a   Triantafyllou, Nikolaos ^a   Evdokimidis, Ioannis ^a   Kilidireas, Constantinos ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Brain MRI; Cognitive function; Corpus callosum; Multiple sclerosis; Neuropsychological assessment; Oligoclonal bands

Indexed keywords

OLIGOCLONAL BAND;

ADULT; ARTICLE; ASSOCIATIVE MEMORY; BABCOCK STORY RECALL TEST IMMEDIATE AND DELAYED RECALL; BLOCK DESIGN AND OBJECT ASSEMBLY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL STUDY; COGNITION; COGNITION ASSESSMENT; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED ORAL WORD ASSOCIATION TEST; CONTROLLED STUDY; DEPTH PERCEPTION; DIGIT SYMBOL SUBSTITUTION TEST; EXECUTIVE FUNCTION; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; OUTCOME ASSESSMENT; REY AUDITORY VERBAL LEARNING TEST; REY OSTERRIETH COMPLEX FIGURE TEST; SELECTIVE ATTENTION; STROOP NEUROPSYCHOLOGICAL SCREENING TEST; TRAIL MAKING TEST; VELOCITY; VISUAL MEMORY; WECHSLER ADULT INTELLIGENCE SCALE; WISCONSIN CARD SORTING TEST; BRAIN; CERVICAL VERTEBRA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PSYCHOLOGY; SPINAL CORD; THORACIC VERTEBRA;

ADULT; BRAIN; CERVICAL VERTEBRAE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; OLIGOCLONAL BANDS; SPINAL CORD; THORACIC VERTEBRAE;

EID: 84945447966     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-015-2303-1     Document Type: Article

References (43)

1. Polman MP, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302
2. Amato MP, Ponziani G (2001) A prospective study on the prognosis of multiple sclerosis. Neurol Sci 21:S831–S838
3. Joseph FG, Hirst CL, Pickersgill TP, Ben-Shlomo Y, Robertson NP, Scolding NJ (2008) CSF oligoclonal bands status informs prognosis in multiple sclerosis: a case control study of 100 patients. J Neurol Neurosurg Psychiatry 80:292–296
4. Zeman AZ, Kidd D, McLean BN, Kelly MA, Francis DA, Kendall BE et al (1996) A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 60:27–30
5. Huttner HB, Schellinger PD, Struffert T, Richter G, Engelhorn T, Bassemir T et al (2009) MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof’s criteria but different lesion patterns. J Neurol 256:1121–1125
6. Imrell K, Landtblom AM, Hillert J, Masterman T (2006) Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 67:1062–1064
7. Koch M, Heersema D, Mostert J, Teelken A, De Keyser J (2007) Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis. Eur J Neurol 14:797–800
8. Reiber H, Ungefehr S, Jacobi C (1990) The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 4:111–117
9. Pichiecchio A, Tavazzi E, Maccabelli G, Ponzio M, Romani A, Schiappacassa R et al (2009) MR peri-CSF lesions and CSF oligoclonal bands in Italian multiple sclerosis. Acta Neurol Scand 120:242–245
10. Romero-Pinel L, Martinez-Yelamos S, Bau L, Matas E, Gubieras L, María Pujal J et al (2011) Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. Eur J Neurol 18:1258–1262
11. Kikuchi S, Fukazawa T, Niino M, Yabe I, Miyagishi R, Hamada T et al (2003) HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands: human leukocyte antigen. Neurology 25:647–651
12. Lundkvist M, Greiner E, Hillert J, Fogdell-Hahn A (2010) Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta. Mult Scler 16:796–800
13. Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41:685–691
14. Schulz D, Kopp B, Kunkel A, Faiss JH (2006) Cognition in the early stage of multiple sclerosis. J Neurol 253:1002–1010
15. Amato MP, Portaccio E, Goretti B, Zipoli V, Hakiki B, Giannini M et al (2010) Cognitive impairment in early stages of multiple sclerosis. Neurol Sci 31:S211–S214
16. Panou T, Mastorodemos V, Papadaki E, Simos PG, Plaitakis A (2012) Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome. Behav Neurol 25:311–326
17. Audoin B, Ibarrola D, Malikova I, Soulier E, Confort-Gouny S, Duong MV et al (2007) Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis: a two-year longitudinal MRI/MRSI study of corpus callosum. Mult Scler 13:41–51
18. Bobholz JA, Rao SM (2003) Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 16:283–288
19. Zakzanis KK (2000) Distinct neurocognitive profiles in multiple sclerosis subtypes. Arch Clin Neuropsychol 15:115–136
20. Ozcan ME, Ince B, Bingol A, Erturk S, Altinoz MA, Karadeli HH et al (2014) Association between smoking and cognitive impairment in multiple sclerosis. Neuropsychiatr Dis Treat 10:1715–1719
21. Assouad R, Louapre C, Tourbah A, Papeix C, Galanaud D, Lubetzki C, Stankoff B (2014) Clinical and MRI characterization of MS patients with a pure and severe cognitive onset. Clin Neurol Neurosurg 126C:55–63
22. Hakiki B, Goretti B, Portaccio E, Zipoli V, Amato MP (2008) “Subclinical MS”: follow-up of four cases. Eur J Neurol 15:858–861
23. Kappos L, Radue EW, O’Connor P, Polman C, Hohlfeld R, Calabresi P et al (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 362:387–401
24. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58:840–846
25. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452
26. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
27. Barkhof F, Rocca M, Francis G, Van Waesberghe JH, Uitdehaag BM, Hommes OR et al (2003) Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon1a. Ann Neurol 53:718–724
28. Anderson M, Alvarez-Cermeno J, Bernardi G et al (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57:897–902
29. Lezak MD, Howiesonm DB, Loring DW (2004) Neuropsychological assessment. Oxford University Press, New York
30. Kokkevi A, Repapi M, Adamou N, Stefanis C (1979) Adjustment and standardization of WAIS in Greek population. University Psychiatric Clinic, Aeginition Hospital, Athens
31. Andreadou E, Chatzipanagiotou S, Constantinides VC, Rombos A, Stamboulis E, Nicolaou C (2013) Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis. Clin Neurol Neurosurg 115:2094–2098
32. Pirtilla T, Nurmikko T (1995) CSF oligoclonal bands, MRI, and the diagnosis of multiple sclerosis. Acta Neurol Scand 92:468–471
33. Rot U, Ledinek AH, Jazbec SS (2008) Clinical, magnetic resonance imaging, cerebrospinal fluid and electrophysiological characteristics of the earliest multiple sclerosis. Clin Neurol Neurosurg 110:233–238
34. Dobson R, Ramagopalan S, Davis A, Giovannoni G (2013) Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry 84:909–914
35. Falip M, Tintore M, Jardi R, Duran I, Link H, Montalban X (2001) Clinical usefulness of oligoclonal bands. Rev Neurol 32:1120–1124
36. Link H, Huang YM (2006) Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 180:17–28
37. Nakashima I, Fujihara K, Miyazawa H, Misu T, Fujimori J, Sato S, Itoyama Y (2005) Relevance of callosal and periventricular MRI lesions to oligoclonal bands in multiple sclerosis. Acta Neurol Scand 113:125–131
38. DeLuca J, Barbieri-Berger S, Johnson SK (1994) The nature of memory impairment in multiple sclerosis: acquisition versus retrieval. J Clin Exp Neuropsychol 16:183–189
39. Potagas C, Giogkaraki E, Koutsis G, Mandellos D, Tsirempolou E, Sfagos C, Vassilopoulos D (2008) Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 267:100–106
40. Stoquart-ElSankari S, Bottin C, Roussel-Pieronne M, Godefroy O (2010) Motor and cognitive slowing in multiple sclerosis: an attentional deficit? Clin Neurol Neurosurg 112:226–232
41. Brissart H, Morele E, Baumann C, Debouverie M (2012) Verbal episodic memory in 426 multiple sclerosis patients: impairment in encoding, retrieval or both? Neurol Sci 33:1117–1123
42. Wieder L, Gade G, Pech LM, Zimmermann H, Wernecke KD, Dorr JM et al (2013) Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study. BMC Neurol 13:167
43. Muhlert N, Atzori M, De Vita E, Thomas DL, Samson RS, Wheeler-Kingshott CA et al (2014) Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions. J Neurol Neurosurg Psychiatry 85:833–839